Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II
- HIV/AIDS situation, WHO Western Pacific Region, 1998. // Weekly Epidemiological Record;4/7/2000, Vol. 75 Issue 14, p110
Reports the number of HIV and AIDS cases in the World Health Organization Western Pacific Region. List of countries with declining HIV prevalence; Determination of sexually transmitted infections other than HIV; Assessment on the gonococcal susceptibility of HIV to antimicrobials.
- AIDS: global lessons from a global epidemic. Mann, Jonathan; Wilson, Mary E. // BMJ: British Medical Journal (International Edition);12/18/93-12/25/93, Vol. 307 Issue 6919, p1574
Focuses on the prevalence of HIV epidemic. Role of the World Health Organization in the development of warning system for the emergence of diseases; Identification of microbial threats to health; Factors affecting the emergence of diseases.
- Dried Blood Spot Specimens Are a Suitable Alternative Sample Type for HIV-1 Viral Load Measurement and Drug Resistance Genotyping in Patients Receiving First-Line Antiretroviral Therapy. Rottinghaus, Erin K.; Ugbena, Richard; Diallo, Karidia; Bassey, Orji; Azeez, Aderemi; DeVos, Joshua; Zhang, Guoqing; Aberle-Grasse, John; Nkengasong, John; Chunfu Yang // Clinical Infectious Diseases;4/15/2012, Vol. 54 Issue 8, p1187
Background. Antiretroviral therapy (ART) is being administered in developing nations at unprecedented numbers following the World Health Organization's (WHO) development of standardized first-line drug regimens. To ensure continued efficacy of these drug regimens, WHO recommends monitoring...
- Classification of HIV infection and disease in women from Rwanda. Lifson, Alan R.; Allen, Susan // Annals of Internal Medicine;2/15/95, Vol. 122 Issue 4, p262
Presents a HIV staging system for sub-Saharan Africa on the basis of an evaluation of the World Health Organization (WHO) system and predictors of mortality. Classification of HIV infection and disease among the women of Kigali, Rwanda; Oral candidiasis as a strong predictor of progression and...
- Low prices for HIV drugs are only one step forward. West, Peter A // BMJ: British Medical Journal (International Edition);2/7/2004, Vol. 328 Issue 7435, p349
Presents a letter to the editor in response to the article by M. Pollock and D. Price entitled "New deal from the World Health Organization," published in the September 13, 2003 edition of this journal.
- Assisted Reproductive Technology for Men and Women Infected with Human Immunodeficiency Virus Type 1. Al-Khan, Anthony; Colon, Jose; Palta, Vidya; Bardeguez, Arlene // Clinical Infectious Diseases;1/15/2003, Vol. 36 Issue 2, p195
In 2001, the World Health Organization reported 4.3 million new human immunodeficiency virus (HIV) infections in adults globally, 41% of which were in women. During the year 2000, 27% of newly diagnosed HIV infections in the United States occurred in women. In developed countries, the perception...
- WHO Lauds India's Effort to Combat HIV Abroad. Varma, K. J. M. // India -- West;7/15/2011, Vol. 36 Issue 34, pA42
The article reports that India was honored by World Health Organization (WHO) for its efforts in providing affordable and effective medicines to fight meningitis and HIV/AIDS in South America and Africa.
- WHO Documents Worldwide Need for Better Drug Abuse Treatment--and Access to It. Kuehn, Bridget M. // JAMA: Journal of the American Medical Association;8/1/2012, Vol. 308 Issue 5, p442
The article provides information on the demand of the World Health Organization (WHO) on the treatment of drug use disorders. According to the WHO drug use disorders is a global problem but many countries do not take it in consideration. According to director of the department of mental health...
- Commentary: Early antiretroviral therapy for HIV infection in sub-Saharan Africa, a challenging new step. Laurent, Christian // Journal of Public Health Policy;2010, Vol. 31 Issue 4, p401
Recent changes in guidelines (World Health Organization (WHO), USA, and likely Europe soon) all move towards earlier initiation of antiretroviral therapy in asymptomatic patients infected with human immunodeficiency virus (HIV). Sonia Menon appropriately questions the feasibility and...